Skip to main content


Government quit test of pricey cancer treatment amid concerns over industry role

By Politico  
   July 10, 2018

Medicare and Medicaid administrators earlier this year quietly killed a plan to pay for a breakthrough, half-million-dollar cancer treatment based on how well it worked, scuttling one of the Trump’s administration’s first and most highly touted attempts to lower the cost of drugs.

Full story

Get the latest on healthcare leadership in your inbox.